Breast Cancer Clinical Trials
Here are the 6 most popular medical studies for
[18F] F-GLN PET/CT Imaging for Breast Cancer
Recruiting1 awardPhase 1
Philadelphia, Pennsylvania
This trial is for patients with breast cancer who have one lesion that is 1.5 cm in diameter or greater. Patients must be at least 18 years old to participate. up to 40 subjects will be observed in this study, with 10 estrogen-receptor-expressing (ER+) and 10 triple-negative breast cancers (TNBC) being given priority. [18F]F-GLN PET/CT will not be used to make treatment decisions, but to evaluate image quality and collect preliminary information on the uptake of [18F]F-GLN in breast cancer. The safety of [18F]F-GLN will
Physical Activity During Chemotherapy for Breast Cancer
Recruiting1 award8 criteria
Chapel Hill, North Carolina
This trial is testing whether being physically active during chemotherapy can help moderate increases in p16 levels. 100 patients with breast cancer will be recruited and monitored throughout their chemotherapy treatment.
Popular filter options for trials
LABC Clinical Trials
View 71 LABC medical studies.
Hormone Therapy
Deslorelin + Hormone Therapy for Breast Cancer Prevention in High-Risk Women
Recruiting1 awardPhase 2
Duarte, California
This trial is studying deslorelin combined with low-dose add-back estradiol and testosterone to see how well it works in preventing breast cancer in premenopausal women who are at high risk for this disease.
Monoclonal Antibodies
Pembrolizumab + Mifepristone for Breast Cancer
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is testing a combination of two drugs to treat advanced breast cancer. The first part of the trial will test the safety of the combination in ten patients. If the combination is safe, the trial will expand to include more patients.
Ductal Carcinoma Clinical Trials
View 71 Ductal Carcinoma medical studies.
Hormone Therapy
Deslorelin + Hormone Therapy for Breast Cancer Prevention in High-Risk Women
Recruiting1 awardPhase 2
Duarte, California
This trial is studying deslorelin combined with low-dose add-back estradiol and testosterone to see how well it works in preventing breast cancer in premenopausal women who are at high risk for this disease.
Monoclonal Antibodies
Pembrolizumab + Mifepristone for Breast Cancer
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is testing a combination of two drugs to treat advanced breast cancer. The first part of the trial will test the safety of the combination in ten patients. If the combination is safe, the trial will expand to include more patients.
ER Positive Clinical Trials
View 22 ER positive medical studies.
Monoclonal Antibodies
Pembrolizumab + Mifepristone for Breast Cancer
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is testing a combination of two drugs to treat advanced breast cancer. The first part of the trial will test the safety of the combination in ten patients. If the combination is safe, the trial will expand to include more patients.
CDK4/6 Inhibitor
Palbociclib + Fulvestrant for Breast Cancer
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial is to see if continuing treatment with palbociclib and adding fulvestrant helps people with hormone-receptor positive breast cancer who have progressed on palbociclib and an aromatase inhibitor.
PR Positive Clinical Trials
View 13 PR positive medical studies.
Monoclonal Antibodies
Pembrolizumab + Mifepristone for Breast Cancer
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is testing a combination of two drugs to treat advanced breast cancer. The first part of the trial will test the safety of the combination in ten patients. If the combination is safe, the trial will expand to include more patients.
CDK4/6 Inhibitor
Palbociclib + Fulvestrant for Breast Cancer
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial is to see if continuing treatment with palbociclib and adding fulvestrant helps people with hormone-receptor positive breast cancer who have progressed on palbociclib and an aromatase inhibitor.
Tyrosine Kinase Inhibitor
Bosutinib + Palbociclib + Fulvestrant for Advanced Breast Cancer
Recruiting1 awardPhase 1
Washington, District of Columbia
This trial is designed to study the safety of a new cancer drug and to see if it works. The drug will be given to patients 5 days a week, with 2 days off, and the dose will be increased gradually to ensure safety. The study will enroll patients in groups of 3, and will observe them for 28 days to see if there are any side effects. If the drug is found to be safe and effective, patients will be able to continue treatment.
Breast Cancer Clinical Trials With No Placebo
View 80 breast cancer medical studies that do not have a placebo group.
Hormone Therapy
Deslorelin + Hormone Therapy for Breast Cancer Prevention in High-Risk Women
Recruiting1 awardPhase 2
Duarte, California
This trial is studying deslorelin combined with low-dose add-back estradiol and testosterone to see how well it works in preventing breast cancer in premenopausal women who are at high risk for this disease.
Monoclonal Antibodies
Pembrolizumab + Mifepristone for Breast Cancer
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is testing a combination of two drugs to treat advanced breast cancer. The first part of the trial will test the safety of the combination in ten patients. If the combination is safe, the trial will expand to include more patients.
View More Trials
See another 59 medical studies focused on .
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.